Clinical Trials Sponsored by Diana Lee Farmer
Total 1211 results
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalActive, not recruitingSmoking Cessation | Lung CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Spaulding Rehabilitation HospitalCompletedBreast Cancer | Breast Cancer Surgery Pain | Stage 0-III Breast CancerUnited States
-
Raphael Bueno, MDMerck Sharp & Dohme LLCWithdrawn
-
Dana-Farber Cancer InstituteNovartis; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedGlioma | Astrocytoma | Low-grade GliomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Celgene CorporationCompletedNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalTerminatedRectal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteChildren's Hospital of Philadelphia; Boston Children's HospitalCompletedNeuroblastoma | Ewings Sarcoma | Non-rhabdomyosarcoma Soft Tissue SarcomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Brigham and Women's HospitalCompletedC-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckHead and Neck NeoplasmsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedColorectal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteSanofi; National Heart, Lung, and Blood Institute (NHLBI)RecruitingChronic Graft Versus Host Disease | Lung Diseases | Bronchiolitis Obliterans | Bronchiolitis Obliterans SyndromeUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; AstraZeneca; Sirtex MedicalRecruitingCholangiocarcinoma | Bile Duct Cancer | Cholangiocarcinoma Non-resectable | Cholangiocarcinoma Metastatic | Metastatic Intrahepatic CholangiocarcinomaUnited States
-
Laminar PharmaceuticalsDana-Farber Cancer Institute; Hackensack Meridian Health; Laminar Pharma IncRecruitingHigh-grade Glioma | Solid Tumor, Unspecified, ChildUnited States
-
Dana-Farber Cancer InstituteYale University; Susan G. Komen Breast Cancer FoundationActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Chugai Pharma USAActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteTerminatedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical CenterTerminated
-
David M. Jackman, MDMassachusetts General Hospital; AstraZenecaCompletedNon-Small Cell Lung CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Millennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; AbbottCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Joyce Liu, MDNational Cancer Institute (NCI); ZentalisNot yet recruitingUterine Cancer | Uterine Serous Carcinoma | Uterine CarcinomaUnited States
-
Susan Chi, MDBristol-Myers Squibb; Epizyme, Inc.RecruitingChordoma | Epithelioid Sarcoma | Atypical Teratoid Rhabdoid Tumor | INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors | SMARCA4-deficient Primary CNS Malignant Tumors | Malignant Rhabdoid Tumor (MRT) | Rhabdoid Tumor of the Kidney (RTK)United States
-
Bradley A. McGregor, MDBristol-Myers Squibb; ExelixisRecruitingRenal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Collecting Duct Renal Cell Carcinoma | Translocation Renal Cell Carcinoma | Unresectable Advanced Renal Cell Carcinoma | Metastatic Ncc Renal Cell CarcinomaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; American Heart AssociationRecruiting
-
Dana-Farber Cancer InstituteTranslational Breast Cancer Research Consortium; Myriad Genetics, Inc.CompletedTriple Negative Breast CancerUnited States
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteActive, not recruitingProstate CancerUnited States
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteCompletedChronic Graft Versus Host DiseaseUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Otsuka America PharmaceuticalCompletedNon-Hodgkin's Lymphoma | CNS LymphomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical CenterTerminatedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Dana-Farber Cancer InstituteSigma Theta Tau International Honor Society of NursingCompletedOther CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; National Institutes of Health (NIH)UnknownGerm Cell Tumor | Central Nervous System Germ Cell TumorUnited States
-
University Hospital, ToulouseDana-Farber Cancer Institute; Celgene Corporation; Janssen-Cilag Ltd.Completed
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Jonsson Comprehensive Cancer CenterCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pharmacia; Brigham and Women's HospitalCompletedEsophageal CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedColorectal CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Brigham and Women's HospitalCompletedMyelofibrosis | Chronic Myelomonocytic Leukemia | Myeloid Metaplasia | Agnogenic Myeloid MetaplasiaUnited States
-
Toni Choueiri, MDBeth Israel Deaconess Medical CenterCompletedRenal Cell CarcinomaUnited States
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
University of WashingtonUniversity of California, Los Angeles; Dana-Farber Cancer InstituteCompletedMedication Adherence
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompletedGlioblastoma | Brain TumorUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedBreast Cancer | Hodgkin's DiseaseUnited States
-
AbbottM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; Norwood Immunology...TerminatedLymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin Disease | Mantle Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Brigham and Women's HospitalCompletedSquamous Cell Carcinoma | Carcinoma of Head/NeckUnited States
-
Dana-Farber Cancer InstituteAmerican Cancer Society, Inc.; Children's Cancer Research FundNot yet recruitingPediatric Cancer | Financial Stress | Disparities | Financial HardshipUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); University of Massachusetts, BostonRecruitingBreast Cancer | Colorectal Cancer | Prostate CancerUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Altor BioScience; Miltenyi Biomedicine GmbHRecruitingSquamous Cell Carcinoma of the Head and Neck | Recurrent Head and Neck Squamous Cell CarcinomaUnited States